By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Development and commercialization of the ADAPT® anti-calcification tissue1.91M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States1.61M84.06%
Germany272K14.22%
Australia33K1.73%
